BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 1873592)

  • 61. Autologous bone marrow transplantation for acute lymphoblastic leukemia.
    Doney K; Buckner CD; Fisher L; Petersen FB; Sanders J; Appelbaum FR; Anasetti C; Badger C; Bensinger W; Deeg HJ
    Bone Marrow Transplant; 1993 Oct; 12(4):315-21. PubMed ID: 8275030
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Hermans J; Labopin M; Apperley J; Gorin NC; Gratwohl A
    Leuk Lymphoma; 1996 Dec; 24(1-2):71-9. PubMed ID: 9049963
    [TBL] [Abstract][Full Text] [Related]  

  • 63. What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?
    Storb R; Pepe M; Anasetti C; Appelbaum FR; Beatty P; Doney K; Martin P; Stewart P; Sullivan KM; Witherspoon R
    Blood; 1990 Sep; 76(5):1037-45. PubMed ID: 2203481
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children.
    Woolfrey AE; Anasetti C; Storer B; Doney K; Milner LA; Sievers EL; Carpenter P; Martin P; Petersdorf E; Appelbaum FR; Hansen JA; Sanders JE
    Blood; 2002 Mar; 99(6):2002-8. PubMed ID: 11877272
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors.
    Lundberg JH; Hansen RM; Chitambar CR; Lawton CA; Gottlieb M; Anderson T; Ash RC
    J Clin Oncol; 1991 Oct; 9(10):1848-59. PubMed ID: 1919635
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia.
    Bacigalupo A; Van Lint MT; Occhini D; Gualandi F; Lamparelli T; Sogno G; Tedone E; Frassoni F; Tong J; Marmont AM
    Blood; 1991 Apr; 77(7):1423-8. PubMed ID: 2009366
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission.
    Bunin N; Carston M; Wall D; Adams R; Casper J; Kamani N; King R;
    Blood; 2002 May; 99(9):3151-7. PubMed ID: 11964277
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients.
    Nishida T; Murayama T; Hirai H; Okamoto S; Sao H; Hara M; Kanamori H; Atsuta Y; Matsuo K; Morishima Y; Kodera Y
    Int J Hematol; 2009 Jan; 89(1):98-105. PubMed ID: 19052693
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival.
    Neudorf S; Sanders J; Kobrinsky N; Alonzo TA; Buxton AB; Gold S; Barnard DR; Wallace JD; Kalousek D; Lange BJ; Woods WG
    Blood; 2004 May; 103(10):3655-61. PubMed ID: 14751924
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Impact of chronic graft-versus-host disease on long-term outcome after allogeneic hematopoietic cell transplantation in adult acute lymphoblastic leukemia].
    Wojnar J; Giebel S; Hołowiecka-Goral A; Krawczyk-Kuliś M; Markiewicz M; Stella-Hołowiecka B; Wylezoł I
    Pol Arch Med Wewn; 2006 Jul; 116(1):671-7. PubMed ID: 17340974
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission.
    Nishiwaki S; Terakura S; Yasuda T; Imahashi N; Sao H; Iida H; Kamiya Y; Niimi K; Morishita Y; Kohno A; Yokozawa T; Ohashi H; Sawa M; Kodera Y; Miyamura K
    Int J Hematol; 2010 Apr; 91(3):419-25. PubMed ID: 20146028
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia.
    DeGast GC; Mickelson EM; Beatty PG; Amos D; Sullivan KM; Schoch HG; Thomas ED; Hansen JA
    Bone Marrow Transplant; 1992 Feb; 9(2):87-90. PubMed ID: 1533333
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation.
    Clift RA; Buckner CD; Thomas ED; Kopecky KJ; Appelbaum FR; Tallman M; Storb R; Sanders J; Sullivan K; Banaji M
    Bone Marrow Transplant; 1987 Oct; 2(3):243-58. PubMed ID: 3332174
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia.
    Crawford SW; Longton G; Storb R
    Bone Marrow Transplant; 1993 Sep; 12(3):225-31. PubMed ID: 8241981
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Graft-versus-leukemia in man: relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantation.
    Sullivan KM; Fefer A; Witherspoon R; Storb R; Buckner CD; Weiden P; Schoch G; Thomas ED
    Prog Clin Biol Res; 1987; 244():391-9. PubMed ID: 3310001
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ex vivo depletion of T cells from bone marrow grafts with CAMPATH-1 in acute leukemia: graft-versus-host disease and graft-versus-leukemia effect.
    Novitzky N; Thomas V; Hale G; Waldmann H
    Transplantation; 1999 Feb; 67(4):620-6. PubMed ID: 10071037
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: A children's oncology group study report.
    Satwani P; Sather H; Ozkaynak F; Heerema NA; Schultz KR; Sanders J; Kersey J; Davenport V; Trigg M; Cairo MS
    Biol Blood Marrow Transplant; 2007 Feb; 13(2):218-27. PubMed ID: 17241927
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High incidence of early leukemic relapse in patients given cyclosporin and T cell depleted HLA-identical sibling marrow transplants for acute leukemia in first remission.
    Atkinson K; Biggs J; Dodds A; Concannon A; Downs K; Ashby M; McKenzie IF
    Aust N Z J Med; 1988 Jun; 18(4):587-93. PubMed ID: 3058104
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Marrow transplant experience in children with acute lymphoblastic leukemia: an analysis of factors associated with survival, relapse, and graft-versus-host disease.
    Sanders JE; Flournoy N; Thomas ED; Buckner CD; Lum LG; Clift RA; Appelbaum FR; Sullivan KM; Stewart P; Deeg HJ
    Med Pediatr Oncol; 1985; 13(4):165-72. PubMed ID: 3892260
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia.
    Wingard JR; Piantadosi S; Santos GW; Saral R; Vriesendorp HM; Yeager AM; Burns WH; Ambinder RF; Braine HG; Elfenbein G
    J Clin Oncol; 1990 May; 8(5):820-30. PubMed ID: 2332770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.